1/11
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Hypothalamus–Pituitary–Ovarian (HPO) Axis
controls the menstrual cycle, ovulation, and production of estrogen and progesterone
how HPO axis works
Hypothalamus: Releases GnRH (gonadotropin-releasing hormone).
Anterior pituitary gland: GnRH stimulates the release of two hormones: FSH and LH
Ovaries: Produce estrogen and progesterone, which regulate the menstrual cycle and prepare the uterus for pregnancy.
Negative feedback: Estrogen and progesterone generally signal the hypothalamus and pituitary to reduce GnRH, FSH, and LH release.
FSH
Stimulates ovarian follicle development and estrogen production
LH
Triggers ovulation and supports progesterone production by the corpus luteum
menstrual cycle
controlled by four hormones: FSH, LH, estrogen, and progesterone
Follicular Phase (Days 1–13)
FSH stimulates follicle growth, increasing estrogen production. Estrogen thickens the uterine lining and eventually triggers an LH surge through positive feedback, leading to ovulation
Ovulation (Around Day 14)
LH surges dramatically, triggering release of the egg from the ovary.
FSH also increases slightly, Estrogen briefly decreases after its preovulatory peak
Luteal Phase (Days 15–28)
ruptured follicle forms the corpus luteum, which produces progesterone and estrogen to maintain the uterine lining for implantation. If pregnancy doesn't occur, the corpus luteum breaks down, causing hormone levels to decrease
Menstruation (Beginning of the Next Cycle)
Falling estrogen and progesterone cause the uterine lining to shed, menstrual bleeding begins, marking Day 1 of a new cycle
Menopause occurs
when the ovaries stop releasing eggs and produce significantly less estrogen and progesterone
Menopause
↓ Estrogen & Progesterone → ↓ Negative Feedback → ↑ GnRH, FSH, and LH
contraindications of estrogen-containing products
Angioedema to estrogen
Abnormal genital bleeding of unknown
origin
Active or current history of DVT (Deep Vein Thrombosis) or PE (Pulmonary Embolism)
Active of current history of thromboembolic disease (stroke, MI)
Known, suspected, or history of breast
cancer
Hepatic impairment
Thrombophilic disorders
Pregnancy